CVS Health (CVS) earnings Q1 2026
CNBC • • general
Key Points:
- CVS Health exceeded first-quarter earnings and revenue expectations, reporting adjusted earnings per share of $2.57 versus the $2.20 expected, and revenue of $100.43 billion compared to the anticipated $95.09 billion.
- The company raised its 2026 profit guidance to $7.30-$7.50 per share from $7-$7.20 and increased expected revenue to at least $405 billion, largely due to strong performance in its insurance unit, Aetna.
- All business segments—insurance, retail pharmacy, and health services—surpassed revenue forecasts, with the insurance segment growing 3% to $35.97 billion and showing improved medical cost management.
- CVS's medical benefit ratio improved to 84.6% from 87.3% a year ago, indicating better profitability in its insurance operations, though the company remains cautious about ongoing high medical costs.
- The health services segment grew 11% to $48.24 billion, driven by Caremark's pharmacy benefits management, while the pharmacy and consumer wellness division's sales remained flat at $31.99 billion.
